Joana Pereira-Vieira

  • Cancer metabolism
  • cell resistance
  • therapeutic strategies
  • Acute Myeloid Leukemia
  • 3-Bromopyruvate

Bachelor´s degree in Applied Biology and Master´s degree in Molecular Genetics from the School of Science at the University of Minho. Research fellow at CBMA – Centre of Molecular and Environmental Biology in collaboration with ICVS – Life and Health Sciences Research Institute (2018-2019). Ph.D. student in Health Sciences in the School of Medicine of the University of Minho (2019-2023).

Scientific Highlights

Project: “Anticancer effect of 3-Bromopyruvate (3BP) in animal model systems of leukemia” funded by NewG LabPharma.
Poster communications: Pereira-Vieira J, Celeiro S, Granja S, Barbosa-Matos C, Ko YH, Preto A, Queirós O, Casal M, Baltazar F. “3-bromopyruvate boosts the effect of chemotherapy in acute myeloid leukemia by reducing cell antioxidant defense”. LPCC, Virtual Conference, 25th September 2020. (Prize for the best poster)
Publications: Pereira-Vieira, Joana, Azevedo-Silva, João, Preto, Ana, Casal, Margarida and Queirós, Odília. “MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions” Biological Chemistry, vol. 400, no. 6, 2019, pp. 787-799.